Results 121 to 130 of about 12,163 (174)

Direct oral anticoagulants after surgical bioprosthetic valve replacement or mitral repair: reconciling valve and atrial fibrillation guidelines. [PDF]

J Thorac Dis
Chevli PA, Bhave PD.
europepmc   +1 more source

A Case of Annular Pustular Psoriasis Possibly Triggered by Cabozantinib and Edoxaban During Nivolumab Therapy. [PDF]

J Dermatol
Nagatake M, Horikawa H, Kakuta R, Adachi T, Fukumoto K, Amagai M, Ito Y.   +6 more
europepmc   +1 more source

Development and Validation of a QuEChERS-LC-MS/MS Method for Simultaneous Determination of Four Direct Oral Anticoagulants in Citrate Plasma and Quantitative Dried Plasma Spots. [PDF]

J Sep Sci
Kocur A.
europepmc   +1 more source

Edoxaban versus Apixaban Outcomes Differences in 8,444 Patients with Atrial Fibrillation from Italy: A Real-World Use Comparison. [PDF]

TH Open
Valladares A, Imperato J, Gupta S, Wang R, Jawla S, Clasen M, Smolnik R, Chen C, Unverdorben M, Ye X, Patti G, Brüggenjürgen B.   +11 more
europepmc   +1 more source

Insights on management of recurrence of Cancer-associated isolated distal deep vein thrombosis. [PDF]

J Thromb Thrombolysis
Jia W, Cui H, Zhang X.
europepmc   +1 more source

Safety and Tolerability of Edoxaban in Filipino Patients With Non-valvular Atrial Fibrillation: A Pilot Post-marketing Surveillance Study. [PDF]

Cureus
Bernan AP, Santos AGV.
europepmc   +1 more source

Impact of Atrial Fibrillation Pattern on Edoxaban Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease: A Secondary Analysis of the EPIC-CAD Randomized Clinical Trial. [PDF]

J Am Heart Assoc
Yu JS, Cho MS, Kang DY, Ahn JM, Lee JB, Oh YS, Lee CH, Choi EK, Lee JH, Kwon CH, Park GM, Choi HO, Park KH, Park KM, Hwang JM, Yoo KD, Cho YR, Kim JH, Hwang KW, Jin ES, Kwon O, Kim KH, Park SJ, Nam GB, Park DW, EPIC‐CAD Investigators.   +25 more
europepmc   +1 more source

Sex-Based Differences in Clinical Outcomes With Edoxaban Therapy: A Prespecified Analysis of the EPIC-CAD Trial. [PDF]

JACC Asia
Kim GH, Cho M, Kim S, Kang DY, Ahn JM, Oh YS, Lee CH, Choi EK, Lee JH, Kwon CH, Park GM, Choi HO, Park KH, Park KM, Hwang J, Yoo KD, Cho YR, Kim JH, Hwang KW, Jin ES, Kwon O, Kim KH, Park SJ, Nam GB, Park DW, EPIC-CAD Investigators.   +25 more
europepmc   +1 more source

The impact of body composition variability on coagulation monitoring in patients on direct oral factor Xa inhibitors for treatment of venous thromboembolism. [PDF]

Front Cardiovasc Med
Kurzmann-Guetl K, Leitner DR, Gary T, Avian A, Beck A, Rabensteiner J, Prueller F, Raggam RB, Brodmann M, Toplak H.   +9 more
europepmc   +1 more source

Essential Renal Bleeding Presenting as Persistent Unilateral Hematuria Successfully Treated With Factor XIII Replacement Therapy: A Case Report. [PDF]

IJU Case Rep
Toyoshima M, Maekawa S, Machida A, Sekiguchi K, Ikarashi D, Kato R, Kanehira M, Sugimura J, Obara W.   +8 more
europepmc   +1 more source